Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24964435 | 0.94 | ENPP1 (0.33) | HCRTR1PRKDCALOX5MMP12MMP13 | |
| SCHEMBL24965039 | 0.94 | PRKDC (0.32) | HCRTR1PRKDCALOX5DUSP3 | |
| SCHEMBL23238290 | 0.94 | CHRNA1 (0.33) | HCRTR1PRKDCALOX5 | |
| SCHEMBL25088852 | 0.93 | HCRTR1 (0.31) | HCRTR1PRKDC | |
| SCHEMBL25088845 | 0.92 | PRKDC (0.31) | HCRTR1PRKDCALOX5 | |
| SCHEMBL19152688 | 0.91 | MMP12 (0.34) | HCRTR1PRKDCALOX5MMP12MMP13 | |
| SCHEMBL23239063 | 0.91 | CHRNA1 (0.32) | — | |
| SCHEMBL23237135 | 0.91 | CHRNA1 (0.32) | HCRTR1PRKDC | |
| SCHEMBL21446295 | 0.91 | PRKDC (0.32) | HCRTR1PRKDCALOX5MMP12MMP13 | |
| SCHEMBL21446663 | 0.91 | PRKDC (0.32) | HCRTR1PRKDCALOX5MMP12MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026162-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026162-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | L1CAM, LEF1, MLX | HCRTR1 3134/4885PRKDC 4878/4885ALOX5 1391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.